Results 1 to 10 of about 803,252 (371)

Changes in medical use of central nervous system stimulants among US adults, 2013 and 2018: a cross-sectional study [PDF]

BMJ Open, 2021
Objective To assess the 5-year changes in the adult medical use of central nervous system (CNS) stimulants with higher risk of dependence and evaluate the population characteristics of users and their medical and/or neurological conditions.Design Cross ...
G Caleb Alexander, Thomas J Moore, Stefan P Kruszewski, Phillip W Wirtz   +3 more
doaj   +4 more sources

Medical use and combination drug therapy among US adult users of central nervous system stimulants: a cross-sectional analysis [PDF]

BMJ Open, 2023
Objective Examine patterns of adult medical use of amphetamine and methylphenidate stimulant drugs, classified in the USA as Schedule II controlled substances with a high potential for psychological or physical dependence.Design Cross-sectional study ...
G Caleb Alexander, Thomas J Moore, Phillip W Wirtz, Jill N Curran   +3 more
doaj   +4 more sources

Central nervous system stimulants and sport practice. [PDF]

Br J Sports Med, 2006
Background and objectives:Central nervous system (CNS) stimulants may be used to reduce tiredness and increase alertness, competitiveness, and aggression. They are more likely to be used in competition but may be used during training to increase the intensity of the training session. There are several potential dangers involving their misuse in contact
Avois L, Robinson N, Saudan C, Baume N, Mangin P, Saugy M.   +5 more
europepmc   +6 more sources

Opinion and prevalence of use of central nervous system stimulants in open population: results of an electronic survey [PDF]

Revista Mexicana de Neurociencia, 2022
Objective: The objective of the study was to know the opinion and prevalence of use of central nervous system stimulant drugs (SDs) in healthy people in open population.
Paulina Flores-Medina, Paul Carrillo-Mora   +1 more
doaj   +2 more sources

A randomized placebo controlled trial demonstrates the effect of dl-methylephedrine on brain functions is weaker than that of pseudoephedrine [PDF]

Scientific Reports
Intellectual drug doping in athletics by using stimulants that affect central nervous system functions has been diversified. Stimulants are regulated by the World Anti-Doping Agency according to their levels of urinary concentration.
Takeshi Sakayori, Yumiko Ikeda, Ryosuke Arakawa, Tsuyoshi Nogami, Amane Tateno   +4 more
doaj   +2 more sources

Central Nervous System Stimulants Limit Caffeine Transport at the Blood-Cerebrospinal Fluid Barrier. [PDF]

Int J Mol Sci, 2022
Ikeda-Murakami K, Tani N, Ikeda T, Aoki Y, Ishikawa T.   +4 more
europepmc   +3 more sources

Predictors of Changes in Height, Weight, and Body Mass Index After Initiation of Central Nervous System Stimulants in Children with Attention Deficit Hyperactivity Disorder. [PDF]

J Pediatr, 2022
Waxmonsky JG, Pelham WE, Baweja R, Hale D, Pelham WE.   +4 more
europepmc   +3 more sources

A Randomized Controlled Trial of Interventions for Growth Suppression in Children With Attention-Deficit/Hyperactivity Disorder Treated With Central Nervous System Stimulants. [PDF]

J Am Acad Child Adolesc Psychiatry, 2020
Waxmonsky JG, Pelham WE, Campa A, Waschbusch DA, Li T, Marshall R, Babocsai L, Humphery H, Gnagy E, Swanson J, Hanć T, Fallahazad N, Pelham WE.   +12 more
europepmc   +3 more sources

Aggregated n-of-1 trials of central nervous system stimulants versus placebo for paediatric traumatic brain injury--a pilot study. [PDF]

Trials, 2014
Nikles CJ, McKinlay L, Mitchell GK, Carmont SA, Senior HE, Waugh MC, Epps A, Schluter PJ, Lloyd OT.   +8 more
europepmc   +3 more sources

Cardiovascular safety of central nervous system stimulants in children and adolescents: population based cohort study. [PDF]

BMJ, 2012
Winterstein AG, Gerhard T, Kubilis P, Saidi A, Linden S, Crystal S, Zito J, Shuster JJ, Olfson M.   +8 more
europepmc   +2 more sources